Polaris Market Research recently published [115+ Pages] research report on “Buccal Drug Delivery System Market Share, Size, Trends, Industry Analysis Report, By Type (Sublingual Films, Buccal Tablets, and Lozenges, Oral Sprays); By Application (Pain Management, Smoking Cessation, Angina Pectoris, Others); By End-Use (Hospitals, Ambulatory Centers, Others), By Region; Segment Forecast, 2022 – 2030” in its research database.
According to the research report, the global buccal drug delivery system market size was valued at USD 2.86 billion in 2021 and is expected to reach USD 6.31 Billion by 2030, growing at a CAGR of 9.6% during the forecast period.
What are Buccal Drug Delivery Systems? How Big is Buccal Drug Delivery System Market?
- Overview
Buccal drug delivery is a therapeutic technique for oral drug delivery in which the drug is administrated by the buccal mucosa of the oral cavity. The drug is mainly placed between the upper gums and cheeks while treating several diseases or disorders. The advantage of this method is that the removal of the left tablet from the patient’s mouth is easy if there is an unfavorable reaction.
Moreover, the buccal drug delivery system includes the rapid absorption of the desired therapeutic dose of the drug into plasma, and the stability of this absorption is preserved during the overall treatment. The increasing predilection of macromolecules that includes absorption enhancers, peptides, and other related molecules is uplifting the buccal drug delivery system market share. Also, the rising convenience of non-ionized drugs is propelling the market.
Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/buccal-drug-delivery-system-market/request-for-sample
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)
Key Highlights of the Report
- A complete analysis, which includes an assessment of the parent market
- Assessment of growth opportunities in key segments and regions
- Important changes in market dynamics
- Comprehensive company profiling of top players in the market
- The current, historical and projected size of the industry by both value and volume
- Certain value chain and supply chain analyses of the industry
- Endorsement to companies for strengthening their presence in the market
Some of the Top Market Players Are:
- Applied Pharma Research
- ARDEA BIOSCIENCES LIMITED
- ARx LLC
- AstraZeneca
- Bayer AG
- BioDelivery Sciences International Inc.
- Catalent
- Cynapsus Therapeutics Inc.
- Reddy’s Laboratories Ltd
- Endo Pharmaceuticals plc
- Hoffmann-La Roche Ltd
- Generex Biotechnology
- GlaxoSmithKline plc
- Indivior PLC
- MedLab
- NAPP PHARMACEUTICALS LIMITED
- Novartis AG
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi
- Takeda Pharmaceutical Company Limited.
- Teva Pharmaceutical Industries Ltd
To Know Additional Information on Market Players, Download Sample PDF Brochure
Growth Driving Factors
- Increasing the use of smaller molecules is propelling the market
The buccal drug delivery system market demand is rising due to drug administration and termination, ease in the growing use of smaller molecules, availability of blood vessels, and immediate immersion of drugs into plasma. The rapid rise in the existence of leading competitors in the medication distribution system market and the availability of pharmaceuticals is anticipated to boost the industry over the assessment period.
Furthermore, rapid absorption, fewer biofluid interaction, fewer side effects, favorable concentration availability at the target site, and a smaller treatment regimen are the factors accelerating the buccal drug delivery system market size. Also, as the number of chronic disease cases is rising across the globe, the requirement for buccal drug administration has increased rapidly. The growing adoption rate of novel healthcare technologies is fuelling the market growth.
Directly Purchase a copy of the report with TOC @ https://www.polarismarketresearch.com/checkouts/12341
Recent Developments by
- In 2021, Becton, Dickinson, and the company will set up a manufacturing unit for drug delivery devices in Spain. This company shall invest an amount of U.S. dollars 200 million for developing the facility.
- In 2020, 3 community hospitals in Japan conducted in vitro and in vivo studies to develop mucoadhesive microparticle-laden gels for oral mucositis.
Segmental Analysis
- The buccal tablets and lozenges segment accounted for the considerable market share
On the basis of product type, the buccal tablets and lozenges segment is considered the largest market share. The factors responsible for the segment’s dominance are cost-effectiveness, consumer acceptance, ease of formulation, and the huge availability of medication candidates for formulation. Also, the sublingual film segment is anticipated to dominate the market over the assessment period owing to the fast availability of large concentrations of medication at a target site and substantial research into evolving controlled-release formulations.
- The smoking cessation segment dominated the market
Based on application, the buccal drug delivery system market segmentations are classified into several segments. Out of all the smoking cessation segments accounted for the highest market share. The responsible factors for the segment’s dominance are treating the addicted people from nicotine or smoking. A buccal medication delivery system is the most preferred and effective method. Nicotine lozenges are more beneficial at delivering a more significant absorption of the medication than gums or other dosage forms.
Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/buccal-drug-delivery-system-market/inquire-before-buying
(Inquire about a report quote OR available discount offers to the sales team before purchase.)
Buccal Drug Delivery System Market: Report Scope
| Report Attribute | Details |
| Market Outlook for 2030 | USD 6.31 Billion |
| Market Size 2021 Value | USD 2.86 Billion |
| Expected CAGR Growth | 9.6% from 2022 – 2030 |
| Base Year | 2021 |
| Forecast Year | 2022 – 2030 |
| Top Market Players | Applied Pharma Research, ARDEA BIOSCIENCES LIMITED, ARx LLC, AstraZeneca, Bayer AG, BioDelivery Sciences International, Inc., Catalent, Cynapsus Therapeutics Inc., Dr. Reddy’s Laboratories Ltd, Endo Pharmaceuticals plc, F. Hoffmann-La Roche Ltd, Generex Biotechnology, GlaxoSmithKline plc, Indivior PLC, MedLab, NAPP PHARMACEUTICALS LIMITED, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi, Takeda Pharmaceutical Company Limited., and Teva Pharmaceutical Industries Ltd |
| Segments Covered | By Type, By Application, By End-Use, By Region |
| Customization Options | Customized purchase options are available to meet your research needs. Explore customized purchase options |
Geographic Overview
- North America is accounted for the highest market share
On a geographical basis, the North American region is considered to have the highest buccal drug delivery system market share and is anticipated to maintain its dominance over the foreseen period. This is due to evolved pharmaceutical sector. Also, the factors driving the regional market are the existence of a large number of market players, increased research to identify suitable drug candidates, significant investment by leading players to enhance the development of innovative formulations, and improved detection and treatment rates.
Further, Asia Pacific is expected to boost the industry over the assessment period due to development in the pharmaceutical industry. Also, the rapid rise in the senior population, the pharmaceutical industry’s development, and a substantial increase in domestic players are the other factors anticipated to boost the regional market growth.
Browse the Detail Report “Buccal Drug Delivery System Market Share, Size, Trends, Industry Analysis Report, By Type (Sublingual Films, Buccal Tablets, and Lozenges, Oral Sprays); By Application (Pain Management, Smoking Cessation, Angina Pectoris, Others); By End-Use (Hospitals, Ambulatory Centers, Others), By Region; Segment Forecast, 2022 – 2030” with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/buccal-drug-delivery-system-market
For Additional Information OR Media Enquiry, Please Mail Us At: sales@polarismarketresearch.com
Key Questions Answered in The Report Include:
- What will the buccal drug delivery system market size and the growth rate be in the forecast period?
- What are the key factors driving the industry?
- What are the business growth strategies adopted by developed and developing regions?
- What are the key outcomes of the five forces analysis?
- Who are the leading players active in the market?
- What’s the competition in this industry, both company, and country-wise?
Polaris Market Research has segmented the buccal drug delivery system market report based on type, application, end-user, and region:
By Type Outlook
- Sublingual Films
- Buccal Tablets and Lozenges
- Oral Sprays
By Application Outlook
- Pain Management
- Smoking Cessation
- Angina Pectoris
- Others
By End Use Outlook
- Hospitals
- Ambulatory Centers
- Others
By Region Outlook
- North America (U.S., Canada)
- Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
- Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
- Latin America (Brazil, Mexico, Argentina)
- Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.
Contact Us:
Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com